1. Qualitative and quantitative analysis of AHH as the suspected toxin, associated with evaluation of individual toxicity risk |
+ |
+ |
2. Endotracheal intubation after evaluation for individual risk of aspiration due to AHH ingestion |
+ |
− |
3. Primary toxin elimination by gastro-intestinal lavage in the intubated patient |
+ |
− |
4. Forced CO2-induced ventilation |
+ |
+ |
5. Central venous access |
+ |
+ |
6. Intravenous cimetidine as bolus (200 mg), then 1600 mg for the initial 24 hours via infusion pump and for the subsequent days |
+ |
+ |
7. Intravenous 400 g glucose/24 hours at admission and on subsequent days |
+ |
+ |
8. Intravenous electrolytes and forced diuresis |
+ |
+ |
9. Liquemin 15,000 IU/24 hours at admission and on subsequent days |
+ |
+ |